Immortalized cell lines of differentiated neuronal cell types can be valuable research tools because they provide homogeneous sources of single cell types. They can be used to elucidate mechanisms of induction without the complicating presence of nontarget cells, a situation impossible to achieve in vivo or in mixed primary cultures. They can also serve as sources of cell-specific molecules, as recipients for such molecules in gene transfer experiments, or as sources for cell transplants into the nervous system. Neuronal cell lines from the CNS are especially valuable since it is difficult to prepare pure populations of primary neurons. In addition, few differentiated cell lines originating from the CNS exist.
Neuronal cell lines have been generated by four methods: (1) from spontaneously arising or chemically induced tumors, (2) by fusion of neurons to neuroblastoma cells, (3) by retroviral infection of neural precursor cells, and (4) by the use of oncogenes driven by cell-specific promoters that direct tumorigenesis to defined neurons in transgenic mice. Although many cell lines have been derived from spontaneous or induced tumors, the majority are relatively undifferentiated (Spengler et al., 1973; Schubert et al., 1974; Waymire and Gilmer-Waymire, 1978) . Many have a mixed neuronal and glial phenotype characteristic of very immature cell types. The PC12 cell line (Greene and Tischler, 1976) and some mouse C-1300 subclones (Amano et al., 1972) do exhibit some differentiated properties. However, these lines are derived from the PNS. Somatic cell hybrids offer the potential for obtaining immortalized cells with a well-differentiated phenotype, since mature CNS neurons can theoretically be used as fusion partners. Unfortunately, the success rate of such fusions is low and most researchers have relied on embryonic neuronal tissue to obtain hybrids that resemble mature neurons to varying degrees (Lee et al., 1990; Choi et al., 199 1 ). An additional major drawback of somatic cell hybrids is the extent to which the neuroblastoma partner may influence the resulting hybrid, since the neuroblastoma parent is of PNS origin. This is of concern because hybrids contain additional chromosomes derived from the neuroblastoma parent and often lose those from the non-neuroblastoma parent. Recently, mesencephalic hybrid lines have been established by the fusion of embryonic mesencephalic cells with a neuroblastoma line (Choi et al., 199 1; Crawford et al., 1992) . Although these lines resemble mature midbrain neurons, they synthesize not only dopamine (DA) but also norepinephrine (NE), which is surprising since mature mesencephalic cells are exclusively dopaminergic (Bjorklund and Lindvall, 1984) . Some of these problems can be circumvented by generating cell lines with retroviral or transgenie technologies. Retroviral infection of primary neuronal cultures can result in neuronal cell lines capable of undergoing differentiation under appropriate conditions (Cepko, 1989; Lendahl and McKay, 1990) . Since the virus requires at least one round of cell division in order to integrate into the host's genome, this approach has been largely limited to the immortalization of cycling precursor cells (Fredericksen et al., 1988; Ryder et al., 1990) . Transplantation experiments have shown that these precursor cells retain their plasticity when implanted into a developing brain, giving rise to cells appropriate for the site of implant (Renfranz et al., 199 1; Snyder et al., 1992) . Retroviral infection has thus been of greatest use for lineage analyses and other developmental studies.
The most direct approach to create cell lines of defined neuronal cell types utilizes tissue-specific promoter elements to direct oncogene expression in transgenic mice (Cory and Adams, 1988; Jenkins and Copeland, 1989) . In this way, very specific cells may be targeted. In the last few years this technique has led to the immortalization of gonadotropin-releasing hormone (GnRH)-cxpressing and retinal amacrine neurons (Hammang et al., 1990; Mellon et al., 1990) , as well as for differentiated cells of many non-neuronal tissues (Hanahan, 1989) . Since the target cell destined for transformation is determined by the regulatory promoter elements used, in theory tumors can be induced in any cell type for which specific regulatory elements are available. For the most part, tumors have been observed in the appropriate tissues, although ectopic expression does occur Cory and Adams, 1988) .
We have used the upstream elements of the rat tyrosine hydroxylase (TH) gene to drive the SV40 T antigen (Tag) oncogene to generate tumors in the TH-producing cells of the CNS and PNS. TH is the first and the rate-limiting enzyme in the catecholamine biosynthetic pathway. It converts L-tyrosine into dihydroxyphenylalanine (L-dopa), from which are sequentially synthesized DA, NE, and epinephrine (E) such that all catecholamine-producing cells express TH. The 5' upstream regulatory region of the TH gene has been well studied (Lewis et al., 1987; Cambi et al., 1989; Fader and Lewis, 1990; Gizang-Ginsberg and Ziff, 1990; Yoon and Chikaraishi, 1992; Banerjee et al., 1992; Fung et al., 1992) , and elements necessary for cellspecific expression in cultured cells (Yoon and Chikaraishi, 1992; Fung et al., 1992) and in transgenic mice (Kaneda et al., 199 1; Banerjee et al., 1992) have been defined. The expression of TH in the nervous system has been well established. It has a specific tissue distribution in the CNS in discrete nuclei mainly in the olfactory bulb (OB), midbrain, and brainstem regions (Bjorklund and Lindvall, 1984) . In the PNS it is most abundant in the chromaffin cells of the adrenal medulla and in sympathetic ganglia (Rothman et al., 1980) . In the rodent CNS (excluding the OB), the total number of TH-producing cells is less than 70,000, scattered across a number of sites, which makes the isolation of pure populations of TH-positive cells very difficult. Since TH in the CNS is expressed only in postmitotic neurons (Specht et al., 198 l) , immortalization of TH-expressing neurons using retroviruses is unlikely. SV40 Tag has been shown to induce tumors in a wide variety of tissues. Though other oncogenes such as c-myc and H-rus have been demonstrated to induce tumors; they are relatively restricted in the types of tissues that they can transform (Davis et al., 1987; Sinn et al., 1987) . SV40 Tag, on the other hand, has been successful in inducing tumors in many cell types and, in particular, has been used to generate tumors in endocrine and neural tissues. For example, endocrine pancreatic tumors have been induced when Tag was under the control of the promoters for insulin (Hanahan, 1985) , glucagon (Efrat et al., 1988) , and vasoactive intestinal peptide (VIP, Murphy et al., 1987) ; anterior pituitary tumors were produced with the promoters for VIP (Murphy et al., 1987) and glycoprotein hormone a-subunit ; retinal and adrenal gland tumors were obtained with the phenylethanolamine N-methyl transferase (PNMT) promoter (Baetge et al., 1988) and hypothalamic tumors have been generated with the GnRH promoter .
We report here the immortalization of cells from the brain and adrenal glands of transgenic mice bearing SV40 Tag under the control of 773 base pairs (bp) of the upstream regulatory region of the rat TH gene. We have established three cell lines that possess a neuronal phenotype, indicated by the presence of neurofilament (NF) proteins and the absence of glial fibrillary acidic protein (GFAP). The lines are strongly catecholaminergic, synthesizing high levels of TH enzyme and producing both DA and NE. They also contain synaptophysin, a protein specific to small synaptic vesicles in neurons and related small vesicles in neuroendocrine cells (Navone et al., 1986; Johnston et al., 1989) .
Materials and Methods
Plusmid construction. A Nar-Nar fragment (-19 to 2562) was deleted from -4.8 THCAT (Cambi et al., 1989) and replaced with a synthetic oligonucleotide containing TH sequences from -19 to + 10 followed by three unique sites (SmaI, NruI, SalI) and NarI half-sites at either end. The resulting plasmid, 4.8 THO, contains 4.8 kilobases (kb) of upstream TH and 10 bp of TH 5' untranslated region followed by the SmaI, NruI, and Sal1 sites. The plasmid retains an ampicillin-resistance gene and a colE1, origin of replication. A 2.7 kb St+BamHl fragment from wild-type SV40 DNA (Fiers et al., 1978) was blunt ended and inserted into the unique SmaI site of 4.8THO to generate 4.8THTag. Digestion with XhoI and Sal1 yielded a linear piece of DNA containing the complete coding sequence for Tag (2.7 kb) under the control of -773 bn of TH. The DNA was nurified from aaarose aels bv the sodium perchlorate method (Chen and Thomas, 1985) and-resuspended at a concentration of 5 rig/d for injections.
Transgenic mice. The procedures were done essentially as described by Hogan et al. (1986) . DNA was injected into the male pronucleus of recently fertilized eggs from B6/D2 Fl donor mice (Taconic Labs). Following an overnight incubation at 37"C, the two-cell embryos were implanted into the oviducts of pseudopregnant CD-1 females (Charles River Labs.). Pups bearing the transgene were identified by a tail blot in which DNA from a tail segment was isolated, bound to nitrocellulose filters, and probed with a radiolabeled DNA fragment corresponding to Tag. Pups were screened for the presence of an un-rearranged transgene by Southern analysis (Maniatis et al., 1982) .
Cell culture. Tumors were removed under sterile conditions and cut into small pieces. These were mechanically triturated in RPM1 1640 medium containing 0.018% type I collagen&e (Worthington Biochemical Corp.) with 0.2% bovine serum albumin (Sigma) and placed at 37°C for 20-25 min. The reaction was stopped by the 'addition of serumcontaining medium, and the cells were triturated again and pelleted. They were then plated onto tissue culture plastic and grown in medium containing RPM1 1640 supplemented with 8% horse serum (Hyclone), 4% fetal bovine serum (GIBCO), 1% penicillin-streptomycin (stocks of 10.000 U/ml nenicillin G and 10,000 &ml strentomvcin sulfate: Irvine Scientific) and 20 U/ml nystatin (GIBCO). The-mixed primary cultures were passaged once a week using 0.12% trypsin without EDTA (Irvine Scientific). Even in primary cultures, few glial or fibroblastic cells were evident. For cloning purposes, cells were grown at a low density and glass cylinders were used to isolate individual colonies that were triturated to clumps of l-10 cells in the presence of 0.12% trypsin (without EDTA), and replated at cloning densities. This procedure was performed three times. A more rigorous treatment to obtain only single cells was not successful even when different substrata or conditioned media from healthy cultures were used for culturing.
PATH. 1 was grown on dishes coated with poly-L-lysine (Sigma) at a concentration of 100 &ml to improve attachment. This procedure did not affect the properties of the cell line.
Irnmunohistochemisty. Tissues and tumors were immersed in Bouin's fixative (75 ml saturated picric acid, 25 ml 37% formaldehyde, 5 ml glacial acetic acid) for 4 hr to overnight depending on tissue thickness, after which time they were treated as required for cryostat or paraffin sectioning. Cryostat (9-l 2 pm) and paraffin (6 pm) sections were usually placed on 0.01% poly+lysine-coated slides. Cell lines were grown on poly-L-lysine-coated glass coverslips placed in a 24-well plate, and were fixed by a 15 min exposure to Bouin's fixative.
Triton X-100 (0.3%) in potassium phosphat+buffered saline (TKPBS) was used for permeabilization and was present until the enzymatic reaction was performed in the last step of the procedure. Hydrogen peroxide (1%) in absolute methanol was added to the sections or cells for 20 min to reduce background due to endogenous peroxidase activity. For Tag detection, tissue sections were treated with 0.003% bacterial protease XXIV (Sigma) in TKPBS for 15 min. This treatment partially digested the cellular proteins, including Tag, thereby better exposing the antigens. Since the proteolytic treatment tended to increase background staining, these sections were routinely blocked with avidin followed by biotin (blocking kit, Vector Labs). These solutions were used undiluted and as provided by the supplier. All sections and cells were incubated in 2% normal goat serum (Vector Labs) and 1% Carnation nonfat dry milk in TKPBS for 30 min to block nonspecific binding prior to addition of primary antibody.
Primary antibody incubations were at 4°C for l-3 d depending on the antigen. TH antiserum (Eugene Tech.) was a rabbit polyclonal antiserum against bovine TH. It was used at a dilution of 1:250 or 1:500, depending on the batch. Tag antiserum (rabbit polyclonal) was a gift from Dr. D. Hanahan (UCSF) and was used at a 1:5000 dilution for tissue sections and at a 1: 10,000 dilution for cells. Anti-synaptophysin was a rabbit polyclonal against the rat antigen. It was a gift of Dr. J. Wang (Tufts Univ.) and was used at a dilution of 1:200. Antibodies against the medium chain of NF and GFAP were gifts of Dr. V. Lee (Univ. Penn.). Anti-NF, a mouse monoclonal, was used at a dilution of l:lO, and anti-GFAP, a rat monoclonal, at a dilution of 1:lOO. The buffer for dilutions contained 1% Carnation nonfat dry milk in T/KPBS with 0.02% sodium azide. Sections were covered with glass coverslips to prevent drying. Biotinylated secondary antibodies (goat anti-rabbit, horse anti-mouse, and goat anti-rat) were obtained from Vector Labs and used at a dilution of I:200 in TKPBS with 1% Carnation milk for 2 hr at room temperature. Antibody reactions were visualized with an enzymatic assay utilizing the peroxidase enzyme linked to avidin (ABC kit, Vector Labs). Sections and cells were incubated in the ABC mix for 1 hr at room temperature. Diaminobenzidine (at 40 mg/ 100 ml in Trisbuffered saline, pH 7.4) and hydrogen peroxide (at 0.003%) acted as substrates and NiCl (at 0.04%) as an enhancer for the reaction, which was allowed to proceed until the blue-black color was visible, but not more than 20 min. All sections and cells were dehydrated in ethanol and xylene, and permanently mounted with Permount (Fisher Scientific).
TH enzyme activity (modified from Rittenhouse et al., 1988) . Cells were grown to 70% confluency on 65 mm plates. They were rinsed twice with cold phosphate-buffered saline (PBS), scraped off, and pelleted at 10,000 rpm for 10 min. The pellet was homogenized in 150 ~1 of a buffer containing 0.1% Triton X-100 in 5 mM Tris (pH 6.0) and recentrifuged. The supematant (10 ~1 aliquots) was assayed in duplicate at 37°C for 6 min in a reaction mix consisting of 200 mM KI-IPO, (pH 6.0) 3.2 mM 6-methyl-5,6,7,8-tetrahydropterin, 80 WM L-tyrosine, 300 PM brocresine, 40 mM p-mercaptoethanol, and 2 x 1 OS U/ml catalase. Eoinenhrine (25 nmol) in 0.1 mM EDTA and 0.5 M Tris (nH 8.6) was used to stop the reaction. Catecholamines were allowed to bind to acidwashed alumina for 15 min with constant shaking. The alumina was then pelleted and washed twice with 0.1 M NaHSO, in 0.5 M Tris (pH 8.6). The bound catechols were eluted with 0.1 M H,PO,, 0.1 mM EDTA and quantitated by HPLC. Protein content in an aliquot of the supernatant usedlfor the assay was determined by the method of Lowry et al. (1951) .
DBH enzyme activity (modified from Sperk et al., 1980) . Cells were grown and pelleted as-above. They were son&ted after resuspension in cold 50 mM sodium acetate DH 6.0 with 1% Triton X-100. After one freeze-thaw cycle, they were centrifuged at 12,000 rpm for 10 min. Protein content in the supematant was measured by the method of Lowry et al. (1951) . Protein (10 pg) was added to 100 ~1 of 1% concanavalin A Sepharose 4B beads in 50 mM sodium acetate (pH 5.5). Dopamine P-hydroxylase (DBH) was allowed to adsorb to the beads for 15 min at 4°C and the beads were pelleted at 12,000 rpm for 3 min. They were washed three times with ice water and resuspended in 200 ~1 of 50 mM sodium acetate (pH 5.5). The enzymatic assay was performed at 37°C for 30 min using 100 ~1 of DBH-bound beads in a final reaction volume of 200 ~1. The reaction mix contained 3 mM dopamine, 4 mM ascorbic acid, 40 mM fumarate, 0.6 mM pargyline, 700 U of catalase, 3 PM copper sulfate, and 50 mM sodium acetate (pH 5.5). The reaction was stopped by chilling on ice and with the addition of 0.5 volumes of 2 M Tris (pH 8.6). The catecholamines were extracted with alumina as described for the TH assav and detected bv HPLC. 7.0). RNA was transferred to a Genescreen membrane by passive capillary flow for at least 20 hr, and cross-linked to the membrane by exposure to 1600 J of UV radiation. The membrane was prehybridized for at least 5 hr at 42°C in a buffer containing 50% formamide, 5 x SSC, 0.1% SDS, 0.1% sodium pyrophosphate, 120 &ml salmon sperm DNA, 10 x Denhardt's reagent, and 10% dextran sulfate. Hybridization was done overnight under similar conditions in the presence of a radioactive probe. The membrane was washed at 65°C under stringent conditions and exposed to Kodak XOMat film for autoradiography.
Sources of DNA for making radiolabeled probes were as follows: TH plasmid RR1.2, Cambi et al. (1989) ; NF plasmid, gift of Dr. N. Cowan, NYU; and PNMT plasmid, gift of Dr. E. Weisberg, Univ. of Pittsburgh. DNA probes with an average specific activity of 180 million cpm/pg were made by random priming of the intact TH and PNMT plasmids (Maniatis et al., 1982) . NF RNA probe of a similar specific activity was made according to standard protocols.
Determination of total catecholamines. Cells were grown on 65 mm plates, washed twice with ice-cold PBS, and scraped off mechanically. The cell pellet was homogenized in 0.1 N HClO, and 1 mM EDTA. After centrifugation for 10 min at 10,000 rpm, the supematant was neutralized with 0.5 vol of 2 M Tris (pH 8.6) and adsorbed to acidwashed alumina. Following this step, the procedure was as described for the TH enzyme assay. In order to measure the amount of catecholamines in the supematant, cells were fed with fresh media 24 hr before the catecholamines were extracted.
Western blots. Cell pellets were resuspended in electrophoresis buffer (3% SDS, 5% glycerol, 0.064 M Tris pH 6.8, 2% P-mercaptoethanol), placed in a boiling water bath for 5 mitt, and stored at -70°C. Protein content in an aliquot was measured by the method of Lowry et al. (195 1) . One hundred microliters of the mix (containing 67 pg total protein) were loaded per lane onto an 8% acrylamide-SDS gel. The proteins were transferred electrophoretically to an Immobilon membrane (Millipore). Nonspecific binding was reduced by incubating the membrane for 1 hr in Tris-buffered saline containing 0.1% Tween-20 (TBST) and 3% Carnation nonfat dry milk. It was then exposed to anti-synaptophysin serum at a 1:500 dilution in the same buffer for 1.5 hr at room temperature. Following three washes in TBST buffer with 3% milk, horseradish peroxidase linked to donkey anti-rabbit antibody was added at a 1:2000 dilution for 40 min at room temperature. The membrane was washed three times in TBST and the bands visualized by an ECL detection system (Amersham).
Results TH-expressing tumors in transgenic mice bearing a TH-Tag transgene. A 783 bp region of the rat TH gene, containing 773 bp of 5' upstream DNA and the first 10 bp of untranslated mRNA, was linked to the complete coding region of the wildtype SV40 Tag (Fiers et al., 1978) . The hybrid gene contained the mRNA initiation site at + 1 from the TH gene and the translation start site from the Tag sequence that also provided the natural splice sites and the polyadenylation site. This linearized construct, devoid of plasmid sequences, was injected into fertilized B6/D2 Fl ova. Seven of the 21 pups contained the transgene in their DNA. Southern analysis showed deletions in the transgene in two of these founders (data not shown), which were therefore discarded; the other founders contained one to five copies of un-rearranged TH-Tag transgene. One female founder, #17, died at 10 weeks of age during pregnancy from a massive adrenal tumor that occupied the top left quadrant of the abdominal cavity. The other four founders bred successfully but mice in three lineages were nonexpressors. The remaining founder, #20, established a lineage in which the progeny consistently developed brain tumors. The age of the animals at the onset of tumors varied from 15 weeks to 8.5 months. It is likely that all animals of this lineage will develop tumors with time. In all cases the tumor-bearing mice demonstrated motor difficulties, and exhibited a hunched posture and an enlarged head. Upon death, the mice were found to have tumors on the ventral HPLC. A C-18 reverse-phase colu'mn (Beckman do.) was used in combination with an electrochemical detector (Waters). The mobile phase contained 7.5% methanol, 50 mM NaH,PO, (pH 3.6), 0.387 mM sodium octyl sulfate, and 0.1 mM EDTA.
Northern analysis. Cells were grown on 150 mm plates. PolyA+ RNA was prepared using the Fast Track mRNA isolation kit (Invitrogen). Northems were performed as described (Maniatis et al., 1982) Sections from the tumors were either treated for immunohistochemical analysis or placed in tissue culture medium. Morphologically, both the adrenal and brain tumors resemble neuroblastomas composed of small, densely packed, undifferentiated cells with scant cytoplasm. Figure 1 illustrates a typical staining pattern for TH and Tag proteins in adrenal and brain tumor sections. Whereas Tag can be seen in all the cells of the tumor, albeit at a variable intensity, TH is patchy in its distribution, appearing primarily in cells within a group or nodule. Interestingly, in lineage 20, expression of Tag is also observed in scattered cell nuclei in nontumorigenic brain areas that lack THpositive cell bodies. In these areas, which include the midbrain, brainstem, and specific layers in the cortex and cerebellum, stained nuclei can be seen intermingled with unstained cells (Fig.   le) . This ectopic distribution of the Tag protein was also ob-" served in the brains of siblings that had not yet developed a tumor.
With -773 bp of TH, therefore, Tag was observed in regions that were both appropriate (brain and adrenal glands) and inappropriate (non-TH-producing brain cells). However in some TH-positive regions like the OB and superior cervical ganglia (SCG), Tag expression was never detected, suggesting that 773 bp of 5' TH information is not sufficient for a completely appropriate in vivo expression.
Derivation of immortalized cell lines. Primary tumor cells from the adrenal tumor of founder female 17 and from a brain tumor of a male offspring of founder 20 were grown as mixed cultures for 3-5 months. Cell lines were then isolated from both the adrenal and brain tumor cultures as described in Materials and Methods. These lines were derived by isolation ofindividual clumps of l-10 cells that were plated at cloning density. The progeny of each clump were subjected to at least two additional t i - Figure 2 . TH and Tag staining in cell lines: TH staining in CATH.a (a), PATH. 1 (b), and PATH.2 (c); Tag staining in CATH.a (d), PATH. 1 (e), and PATH.2 v); control staining with normal goat serum in CATH.a (g), PATH.1 (h), and PATH.2 (i). All cells were grown on poly+lysine-coated glass coverslips. Scale bar, 20 pm for all but g, which is at a higher magnification to show the absence of cellular staining.
cycles of similar selection. After the first cycle, cells were tested for the presence of TH by immunochemical means. Approximately 50% of the adrenal lines and 12% of the brain lines contained TH. From the adrenal culture, two cell lines, PATH. 1 and PATH.2 (for peripheral adrenergic TH-expressing), have been studied extensively. They have been passaged at least once a week since February 199 1. The brain culture yielded one strongly catecholaminergic cell line, CATH.a (for central adrenergic TH-expressing), which has been cultured since April 1991. CATH.a and PATH.2 attach well to uncoated plastic tissue culture dishes, whereas PATH. 1 adheres less well to standard culture plates. All three cell lines have since been frozen in liquid nitrogen and successfully thawed. Figure 2 shows the morphology and immunochemical staining patterns for TH and Tag in these three cell lines. All three lines grow in clumps, lack appreciable processes, and appear relatively undifferentiated, with large nuclei and scant cytoplasm. They maintain this morphology when plated on poly-Llysine, collagen, laminin, or irradiated mouse NIH3T3 cells, or in defined media in the absence of serum. However, they stain very strongly for TH and Tag. The expected compartmentalization of TH and Tag is evident in that the TH antibody stains the cytoplasm, while the Tag staining is restricted to the nucleus. While Tag staining is very robust and homogeneous, staining for TH is typically heterogeneous and of variable intensity. The same result was obtained with both a rabbit polyclonal and a mouse monoclonal antibody against TH. We have observed a similar heterogeneity in the PC8b cell line, a subclone of the PC12 cell line (Tank et al., 1990 demonstrating expression of TH protein in cells undergoing DNA replication. Non-catecholaminergic cell lines such as NIH3T3 and ATT20 failed to stain with either TH or Tag antiserum (data not shown).
TH mRNA expression in cell lines. To confirm biochemically that TH is expressed in these cells, a Northern analysis was performed on polyA+ RNA. Figure 3 shows that all three THTag lines have a strong band at 1.9 kb, the position of TH mRNA. As expected, PC8b cells show this band although at a reduced level compared to the TH-Tag lines, and the negative cell lines NIH3T3 and B103 (a CNS neuroblastoma) do not.
The three TH-Tag cell lines therefore contain abundant TH mRNA as judged by Northern blot analysis, and TH protein as judged by immunocytochemistry.
Activities of catecholaminergic enzymes in cell lines. To determine whether the TH protein is enzymatically active, we measured TH activity in vitro. Table 1 shows that PATH.l, PATH.2, and CATH.a have TH-specific activities of 776, 233, and 1129 pmol/mg protein/min, respectively. Since the next enzyme in the catecholamine biosynthetic pathway, dopa-decarboxylase, is found in most cells, the three cell lines should be capable of synthesizing the first major catecholamine, DA. To determine if the cells synthesize the second catecholamine in the pathway, NE, we assayed for DBH, which converts DA to NE. As Table 1 indicates, all three cell lines contain an active form of DBH, which suggests that these cells should also produce Values are expressed as pmol/min/mg protein f SD (n); n.d., not determined. TH enzyme activities were determined essentially as described in Rittenhouse et al. (1988) , and DBH activities were measured according to Sperk et al. (1980) , both with slight modifications. See Materials and Methods.
NE if the required cofactors for TH and DBH are also present in the cells. Catecholamine production in cell lines. To evaluate catecholamine production directly, DA and NE were measured in cell extracts by a reverse-phase HPLC system. As with the enzymatic assays, cells were plated in equal numbers and grown to similar densities before the catecholamines were extracted. High levels of both DA and NE can be detected in the cell extracts, while E was not detected even under conditions of high sensitivity. DA levels in all three cell types are higher than the NE levels, the ratio of DA to NE being approximately 1.9 for PATH. 1,2.5 for PATH.2, and 2.4 for CATH.a (Table 2) . Analysis of the tissue-culture medium also revealed large amounts of the two catecholamines (Table 2) as well as of their degradation products (data not shown), suggesting a high basal secretion and turnover. Taken together with the enzyme assays, these results suggest that all three cell lines are noradrenergic. The lack of E in these cell lines is consistent with the absence of mRNA for PNMT, the enzyme required for the conversion of NE to E. Figure 4 shows that only RNA from the adrenal gland contains the 1.1 kb band specific to PNMT. None of the other cell lines, including PC1 2, were found to possess this RNA species.
Expression of a neuronal phenotype. The lines were assayed for the expression of NF, the intermediate filaments characteristic of neurons (Lazarides, 1982) . NFs are composed of three separate proteins of 68 kDa (light chain), 150 kDa (medium chain), and 200 kDa (heavy chain) (Hoffman and Lasek, 1975) . three cell types. The distribution of NF within cells is variable but when present it is always cytoplasmic. In contrast, when cells were stained with an antibody against GFAP, the intermediate filament characteristic of glial cells, no reaction was detected (Fig. 5d-f . To confirm the presence of NF using an alternate approach, mRNA from the cell lines was analyzed for the presence of the NF light chain. In Figure 6 the two RNA species of 2.5 kb and 4.0 kb (Lewis and Cowan, 1985) encoding the light chain RNA are readily apparent in PATH.1 and CATH.a, while PATH.2 has less of the 68 kDa NF RNA. Nevertheless, these data in conjunction with the antibody staining demonstrate that all three lines express NFs and lack GFAP, suggesting a neuronal or neuroendocrine origin. Control cell lines, NIH3T3 and B103, lack NF RNA.
Expression of synaptophysin. A polyclonal antibody against synaptophysin (~38) exhibits a similar and distinct staining pattern in all three lines. The staining is largely confined to a single, intense spot near the nucleus (Fig. 7) . Control experiments showed no staining when primary antiserum was omitted or when a non-neuronal cell line, NIH3T3, was used.
Synaptophysin in neurons and endocrine cells is subject to differential modification by glycosylation and sulfation, resulting in multiple forms on SDS gels (Navone et al., 1986; RegnierVigouroux et al., 199 1) . To determine if indeed there were molecular differences in the protein between the three cell lines, a Western blot using the same polyclonal antibody was performed. As shown in Figure 8 , all three cell lines contain p38 proteins (indicated by a bracket) that can be resolved into several closely migrating species. PATH. 1 has a higher level of synaptophysin than PATH.2 and has fewer different isoforms that can be resolved on SDS gels. CATH.a has the highest concentration of p38 with several clearly distinguishable bands. In general, all three lines contain p38 proteins that migrate more slowly than those derived from a control rat brain synaptosomal fraction.
Discussion
The development of TH-expressing brain tumors in transgenic mice carrying SV40 Tag directed by TH regulatory sequences demonstrates that the CNS catecholaminergic neurons are indeed susceptible to the effects of Tag. This is in contrast to the results obtained with the glucagon enhancer directing expression of Tag to neurons in the brainstem (Efrat et al., 1988) . While Tag expression was detectable in specific brainstem neurons that are thought to be glucagon expressing, no tumors arose. In the same animals, Tag could be seen in the appropriate a-cells of the endocrine pancreas as early as embryonic day 10 when those cells are first detected (Pictet and Rutter, 1972) . At this site, the oncogene continued to be expressed throughout adulthood, leading to the formation of overt tumors by 9-l 2 months. Since Tag-expressing neurons in the CNS failed to proliferate, a possible implication was that CNS neurons were not susceptible to the effects of an oncogene. Recent experiments with the GnRH promoter driving SV40 Tag have demonstrated that this is not the case for all neurons . Not only did the transgenic mice develop tumors, but the neuronal cell lines isolated from such tumors continued to produce both GnRH and Tag. While it is likely that glucagon expression in the CNS is restricted to postmitotic neurons, the GnRH-expressing hypothalamic neurons, which are thought to arise from the olfactory placode, have been shown to express the hormone while still dividing (Schwanzel-Fukuda and Pfaff, 1989) . These results might suggest that Tag needs to be expressed in a dividing cell in order to initiate transformation. This explanation is not entirely consistent with results using a PNMT-Tag transgene (Hammang et al., 1990) . Retinal tumors were observed in these transgenic mice in amacrine cells that are thought to be postmitotic at the time when PNMT is first expressed. However, the cell type of origin for the amacrine cell cultures derived from these tumors is unclear since these cells did not produce PNMT. They also did not express other catecholaminergic properties, although the lack of TH and other catecholaminergic traits may be due to the fact that a significant percentage of PNMT-positive amacrine cells normally do not produce TH (Hadjiconstantinou et al., 1984; Park et al., 1986) . Nevertheless, the lack of PNMT in cultured cells was surprising and was suggested by the authors to be due to a repression of the differentiated phenotype by Tag. Therefore, the issue as to whether a postmitotic neuron can be immortalized by the action of Tag remained unresolved in these experiments. Our results clearly show that TH-producing CNS tumors can be obtained despite the fact that TH expression in the brain is observed only in postmitotic neurons in viva (Specht et al., 198 1) . One possibility for the success of the TH promoter may be due to the fact that TH is an early marker of differentiated catecholaminergic neurons. In the rat CNS, TH is first detected in cells at embryonic day 10.5, within 1 d of the birth of these cells (Foster et al., 1985) . Thus, even though TH is expressed by postmitotic neurons, the presence of Tag so early in development might allow the cell to reenter the cell cycle while maintaining TH expression. In contrast, expression of Tag late in development, with the glucagon or PNMT promoter constructs, may be incapable of driving a neuron back into the cell cycle after it has been withdrawn from the cycle for a number of days. This differential susceptibility of a neuron to oncogenesis based on its developmental status could also account for the lack of tumors in some tissues and their presence in others.
The observation that brain tumors only arose in adults and at various ages from 15 weeks to 8.5 months, but were always present in the same location in the brain even though Tag itself was present in other regions, implies two things: first, that Tag by itself is not sufficient to induce tumors in the brain, and second, that some cells in the midbrain or brainstem are more likely than others to undergo complete transformation.
The observation that SV40 Tag requires additional transforming events in order to cause neoplasia is well established. The multistep process hypothesized for tumorigenesis (Foulds, 1958) has been strongly supported by experiments with primary cells in tissue culture (Land et al., 1983; Yancopoulos et al., 1985) and with transgenic mice in vivo (Hanahan, 1985; Mahon et al., 1987; Sinn et al., 1987) . The lack of brain tumors with the glucagon-Tag transgene (Efmt et al., 1988) could be due to the smaller numbers of glucagon-positive cells as compared to the number of TH-positive cells. The small number of glucagon-positive cells would reduce the number of potential targets for subsequent "hits" needed for full transformation.
The fact that TH-producing tumors always arose in the same location in the brain demonstrates that cells in this area are more prone to neoplasia. Possibly, Tag is expressed earlier in development in these susceptible cells. Alternatively, it may be that the TH-expressing cells of this region can transcribe Tag more efficiently because of the presence of appropriate trans- regions. This difference in Tag levels might account for the relative ease with which transformation is accomplished in THexpressing cells. The absence of Tag staining in some TH-expressing tissues such as OB and SCG is likely to reflect the lack of appropriate tissue-specific elements in 773 bp of TH upstream region. A similar pattern of Tag expression was found in transgenic mice in which 2.8 kb of 5' TH DNA was used (C. Suri and D. M. Chikaraishi, unpublished observations). While these transgenic mice developed CNS tumors similar to the -773 TH-Tag mice, they also failed to express Tag in the OB and SCG. Recently, Kaneda et al. (199 l) , using the entire coding region ofthe human TH gene including 2.5 kb of 5' flanking DNA and 0.5 kb of 3' flanking DNA, demonstrated a strong expression in appropriate brain regions and adrenal glands as well as inappropriate expression in CNS regions like the striatum and hippocampus. In fact, further in situ and immunohistochemical analyses extended the areas of ectopic expression in the CNS (Nagatsu et al., 199 1) . Unfortunately, expression in the OB and SCG was not reported in these studies. In contrast, a longer 5' flanking region (4.8 kb) of the rat TH gene appears to contain all the elements for correct tissue-specific expression in transgenic mice (Banerjee et al., 1992) . Creation of transgenic mice bearing the 4.8 TH-Tag construct was in fact attempted but only 1 of 47 pups carried the transgene and that one lineage was nonexpressing, suggesting that the presence of the transgene may have had a deleterious effect on the development of the fetus (Suri and Chikaraishi, unpublished observations).
Several lines of evidence demonstrate that CATH.a, PATH. 1, and PATH.2 are noradrenergic. They synthesize active forms of the enzymes TH and DBH and produce the catecholamines DA and NE. The activities of the two enzymes are similar to those in the PC12 cell line. The activity of TH in PC12 cells, as initially reported, was 39 f 5 pmol/min/mg protein (Greene and Tischler, 1976) which is 6-30-fold less than in the THTag lines. DBH, on the other hand, has an activity level of 806 + 84 pmol/min/mg protein in PC12 cells, which is approximately five-to sevenfold more than in the TH-Tag lines. The levels of DA and NE in PC12 cells are 16.6 ? 1.7 and 6.1 + 6 nmol/mg protein, respectively, which are higher than in the THTag lines. This may be because the TH-Tag lines secrete large amounts of catecholamines into the tissue culture medium.
The presence of NFs, the intermediate filaments in neurons, synaptophysin or p38 in the TH-Tag lines suggests the existence of synaptic vesicles, although the presence of vesicles needs to be confirmed by ultrastructural analysis. It is interesting that the apparent molecular weight of p38 in all three cell lines is higher than in the rat brain synaptosomal preparation. This may be due to different posttranslational modifications in the transformed cells, since other neuroendocrine tumors and neuroblastomas also exhibit these differences (Weidenmann and Huttner, 1989) . Synaptophysin or p38 is an integral membrane protein with a molecular weight of 38 kDa. It is inserted in the membranes of small vesicles found only in neurons and neuroendocrine cells (Navone et al., 1986) . In neurons these vesicles have been shown to function as storage sites for non-peptidergic neurotransmitters and to participate in their regulated release via exocytosis. In endocrine cells the function of p38-containing vesicles is not well understood (Johnston et al., 1989) . The pattern of staining for synaptophysin in our cells is very similar to that in PC12 cells, where the majority of staining has been shown to be centered about the Golgi complex (Johnston et al., 1989) . If synaptophysin is incorporated into vesicles they may tend to pool near the Golgi complex, their site of synthesis. Since PATH and CATH.a lack neurites under normal culture conditions, they may lack the machinery necessary to transport vesicles to the periphery and hence accumulate more vesicles over the Golgi complex.
The small cell size and the large nuclear to cytoplasmic ratio suggest that the three lines have originated from relatively immature cells. The PATH lines are likely to have arisen from precursors in the chromaffin lineage in the adrenal medulla. The lack of E is consistent with the immortalization of a precursor cell, since immature sympathoadrenal cells tend to be noradrenergic. The noradrenergic phenotype of CATH.a is consistent with an origin in the NE neurons ofthe brainstem mainly located in the locus coeruleus and lateral tegmental area. However, a more rigorous biochemical and physiological examination is required before the origin can be fully established, since it may be that some dopaminergic cells of the midbrain express NE transiently during development (Choi et al., 199 1) . It would be of interest to determine whether CATH.a bears receptors for GABA (Cedarbaum and Aghajanian, 1976) 5-HT (Segal, 1979) , opiates (Atweh and Kuhar, 1977) , and NE (Aghajanian et al., 1977) as has been demonstrated for locus coeruleus neurons.
In conclusion, our results demonstrate that promoter directed oncogenesis in transgenic animals can be used to establish CNS cell lines from postmitotic neurons. Since our cell lines retain high levels of catecholamine expression, they should be useful for a variety of studies involving gene regulation and transplantation and should serve as good sources for the isolation of tissue-specific transcription factors.
